We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Amdocs
DOX
$6.04B
| $14.2M | 0.07% |
143,432
+56,323
| +65% | +$5.3M |
|
377
Tenaris
TS
$27B
| $14.2M | 0.07% |
472,806
+303,420
| +179% | +$8.43M |
|
378
Thomson Reuters
TRI
$44B
| $14M | 0.07% |
102,197
-50,875
| -33% | -$6.83M |
|
379
SM Energy
SM
$7.74B
| $13.9M | 0.07% |
439,660
+128,367
| +41% | +$3.63M |
|
380
Loews
L
$23.2B
| $13.8M | 0.07% |
233,048
-81,162
| -26% | -$4.7M |
|
381
ZTO Express
ZTO
$17.6B
| $13.8M | 0.07% |
551,684
-334,928
| -38% | -$9.22M |
|
382
State Street
STT
$51.8B
| $13.8M | 0.07% |
188,562
-13,622
| -7% | -$979K |
|
383
Acuity Brands
AYI
$10.8B
| $13.7M | 0.06% |
84,038
+62,135
| +284% | +$9.92M |
|
384
Equinor
EQNR
$97B
| $13.5M | 0.06% |
462,139
-456,779
| -50% | -$13M |
|
385
Hormel Foods
HRL
$13.2B
| $13.5M | 0.06% |
334,484
+250,458
| +298% | +$10M |
|
386
Steel Dynamics
STLD
$37.7B
| $13.3M | 0.06% |
122,527
+11,229
| +10% | +$1.14M |
|
387
Terex
TEX
$7.75B
| $13.3M | 0.06% |
221,985
-115,601
| -34% | -$5.73M |
|
388
Bumble
BMBL
$356M
| $13.3M | 0.06% |
789,885
+657,461
| +496% | +$11.4M |
|
389
New Oriental
EDU
$8.56B
| $13.2M | 0.06% |
334,836
+100,781
| +43% | +$4.03M |
|
390
Mohawk Industries
MHK
$9.17B
| $13.2M | 0.06% |
127,553
-2,298
| -2% | -$225K |
|
391
Regeneron Pharmaceuticals
REGN
$81.7B
| $13.2M | 0.06% |
18,308
+5,464
| +43% | +$4.21M |
|
392
SiTime
SITM
$20.9B
| $13.1M | 0.06% |
111,403
+35,770
| +47% | +$3.9M |
|
393
TJX Companies
TJX
$171B
| $13.1M | 0.06% |
154,546
+131,361
| +567% | +$10.4M |
|
|
APLS
394
DELISTED
Apellis Pharmaceuticals
APLS
| $13.1M | 0.06% |
143,402
+77,167
| +117% | +$6.66M |
|
395
RPM International
RPM
$14.8B
| $13M | 0.06% |
144,893
+47,093
| +48% | +$3.87M |
|
396
Herc Holdings
HRI
$5.7B
| $12.9M | 0.06% |
94,362
+22,085
| +31% | +$2.44M |
|
397
American Water Works
AWK
$26.8B
| $12.9M | 0.06% |
90,456
+1,264
| +1% | +$186K |
|
398
Yeti Holdings
YETI
$3.8B
| $12.9M | 0.06% |
332,181
-163,940
| -33% | -$6.35M |
|
399
International Flavors & Fragrances
IFF
$21.7B
| $12.8M | 0.06% |
+160,428
| New | +$13.8M |
|
400
TSMC
TSM
$2.23T
| $12.7M | 0.06% |
+125,963
| New | +$11.7M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.